Skip to main content
logo
Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia flag Australia · Delayed Price · Currency is AUD
2.100
+0.010 (0.48%)
Sep 17, 2026, 4:10 PM AEST

Clarity Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
7837988041,689182132
Market Cap Growth
-34.78%-0.69%-52.42%825.73%38.70%-
Enterprise Value
6055726921,65110735
Last Close Price
2.102.142.505.420.700.51

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
74.4375.8384.93146.7918.6220.37
PB Ratio
4.214.298.9111.552.641.43
P/TBV Ratio
4.214.298.9111.552.641.43

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
57.5054.3373.18143.4910.875.40

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-0.96-0.96-0.93-0.93-0.94-1.00
Net Debt / EBITDA Ratio
1.651.651.223.102.485.43
Net Debt / FCF Ratio
1.921.921.533.122.366.83
Asset Turnover
0.070.070.070.100.110.11
Quick Ratio
15.4915.499.0818.449.9513.19
Current Ratio
16.0916.099.6919.0510.1713.26
Return on Equity (ROE)
-77.55%-77.55%-54.37%-39.28%-30.48%-42.23%
Return on Assets (ROA)
-45.12%-45.12%-33.76%-23.87%-18.65%-17.41%
Return on Capital Employed (ROCE)
-58.00%-58.00%-76.10%-30.20%-38.00%-18.50%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-13.69%-13.44%-8.00%-2.51%-13.48%-18.06%
FCF Yield
-11.85%-11.63%-6.84%-2.59%-15.10%-10.28%
Buyback Yield / Dilution
-15.30%-15.30%-16.86%-5.22%-4.81%-40.37%